Carmen Tur
Carmen Tur
Queen Square MS Centre, UCL Institute of Neurology
Verified email at ucl.ac.uk
TitleCited byYear
Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis?
M Tintore, A Rovira, J Rio, C Tur, R Pelayo, C Nos, N Téllez, H Perkal, ...
Neurology 70 (13 Part 2), 1079-1083, 2008
3352008
Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis—establishing disease prognosis and monitoring patients
MP Wattjes, À Rovira, D Miller, TA Yousry, MP Sormani, N De Stefano, ...
Nature Reviews Neurology 11 (10), 597, 2015
2432015
Defining high, medium and low impact prognostic factors for developing multiple sclerosis
M Tintore, A Rovira, J Río, S Otero-Romero, G Arrambide, C Tur, ...
Brain 138 (7), 1863-1874, 2015
2362015
Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis—clinical implementation in the diagnostic process
À Rovira, MP Wattjes, M Tintoré, C Tur, TA Yousry, MP Sormani, ...
Nature Reviews Neurology 11 (8), 471, 2015
2272015
Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis—clinical implementation in the diagnostic process
À Rovira, MP Wattjes, M Tintoré, C Tur, TA Yousry, MP Sormani, ...
Nature Reviews Neurology 11 (8), 471, 2015
2272015
Relationship between MRI lesion activity and response to IFN-β in relapsing–remitting multiple sclerosis patients
J Rio, A Rovira, M Tintoré, E Huerga, C Nos, N Tellez, C Tur, ...
Multiple Sclerosis Journal 14 (4), 479-484, 2008
1422008
Neurite dispersion: a new marker of multiple sclerosis spinal cord pathology?
F Grussu, T Schneider, C Tur, RL Yates, M Tachrount, A Ianuş, ...
Annals of clinical and translational neurology 4 (9), 663-679, 2017
682017
Early brain pseudoatrophy while on natalizumab therapy is due to white matter volume changes
A Vidal-Jordana, J Sastre-Garriga, F Pérez-Miralles, C Tur, M Tintoré, ...
Multiple Sclerosis Journal 19 (9), 1175-1181, 2013
672013
Change in the clinical activity of multiple sclerosis after treatment switch for suboptimal response
J Río, M Tintoré, J Sastre‐Garriga, C Nos, J Castilló, C Tur, M Comabella, ...
European journal of neurology 19 (6), 899-904, 2012
602012
Deep gray matter volume loss drives disability worsening in multiple sclerosis
A Eshaghi, F Prados, WJ Brownlee, DR Altmann, C Tur, MJ Cardoso, ...
Annals of neurology 83 (2), 210-222, 2018
592018
Do multimodal evoked potentials add information to MRI in clinically isolated syndromes?
R Pelayo, X Montalban, T Minoves, D Moncho, J Rio, C Nos, C Tur, ...
Multiple Sclerosis Journal 16 (1), 55-61, 2010
592010
Reduced gamma-aminobutyric acid concentration is associated with physical disability in progressive multiple sclerosis
N Cawley, BS Solanky, N Muhlert, C Tur, RAE Edden, ...
Brain 138 (9), 2584-2595, 2015
582015
Fatigue management in multiple sclerosis
C Tur
Current treatment options in neurology 18 (6), 26, 2016
522016
Primary progressive multiple sclerosis diagnostic criteria: a reappraisal
X Montalban, J Sastre-Garriga, M Filippi, Z Khaleeli, N Tellez, ...
Multiple Sclerosis Journal 15 (12), 1459-1465, 2009
482009
Neurofilament light chain level is a weak risk factor for the development of MS
G Arrambide, C Espejo, H Eixarch, LM Villar, JC Alvarez-Cermeño, ...
Neurology 87 (11), 1076-1084, 2016
462016
Brain atrophy in natalizumab-treated patients: a 3-year follow-up
J Sastre-Garriga, C Tur, D Pareto, A Vidal-Jordana, C Auger, J Río, ...
Multiple Sclerosis Journal 21 (6), 749-756, 2015
422015
Longitudinal evidence for anterograde trans-synaptic degeneration after optic neuritis
C Tur, O Goodkin, DR Altmann, TM Jenkins, K Miszkiel, A Mirigliani, C Fini, ...
Brain 139 (3), 816-828, 2016
412016
Interferon beta-1b for the treatment of primary progressive multiple sclerosis: five-year clinical trial follow-up
C Tur, X Montalban, M Tintoré, C Nos, J Río, FX Aymerich, L Brieva, ...
Archives of neurology 68 (11), 1421-1427, 2011
382011
Association of autonomic dysfunction with disease progression and survival in Parkinson disease
E De Pablo-Fernandez, C Tur, T Revesz, AJ Lees, JL Holton, TT Warner
JAMA neurology 74 (8), 970-976, 2017
352017
Assessing treatment outcomes in multiple sclerosis trials and in the clinical setting
C Tur, M Moccia, F Barkhof, J Chataway, J Sastre-Garriga, AJ Thompson, ...
Nature Reviews Neurology 14 (2), 75, 2018
342018
The system can't perform the operation now. Try again later.
Articles 1–20